What is the role of current mass spectrometry in pharmaceutical analysis?

Autor: Khalikova M; Department of Analytical Chemistry, Faculty of Pharmacy in Hradec Králové, Charles University, Hradec Králové, Czech Republic.; Department of Chemistry, Faculty of Science, University of Hradec Králové, Hradec Králové, Czech Republic., Jireš J; Department of Analytical Chemistry, Faculty of Chemical Engineering, UCT Prague, Prague, Czech Republic.; Department of Development, Zentiva, k. s., Praha, Praha, Czech Republic., Horáček O; Department of Pharmaceutical Chemistry and Pharmaceutical Analysis, Faculty of Pharmacy in Hradec Králové, Charles University, Hradec Králové, Czech Republic., Douša M; Department of Development, Zentiva, k. s., Praha, Praha, Czech Republic., Kučera R; Department of Pharmaceutical Chemistry and Pharmaceutical Analysis, Faculty of Pharmacy in Hradec Králové, Charles University, Hradec Králové, Czech Republic., Nováková L; Department of Analytical Chemistry, Faculty of Pharmacy in Hradec Králové, Charles University, Hradec Králové, Czech Republic.
Jazyk: angličtina
Zdroj: Mass spectrometry reviews [Mass Spectrom Rev] 2024 May-Jun; Vol. 43 (3), pp. 560-609. Date of Electronic Publication: 2023 Jul 28.
DOI: 10.1002/mas.21858
Abstrakt: The role of mass spectrometry (MS) has become more important in most application domains in recent years. Pharmaceutical analysis is specific due to its stringent regulation procedures, the need for good laboratory/manufacturing practices, and a large number of routine quality control analyses to be carried out. The role of MS is, therefore, very different throughout the whole drug development cycle. While it dominates within the drug discovery and development phase, in routine quality control, the role of MS is minor and indispensable only for selected applications. Moreover, its role is very different in the case of analysis of small molecule pharmaceuticals and biopharmaceuticals. Our review explains the role of current MS in the analysis of both small-molecule chemical drugs and biopharmaceuticals. Important features of MS-based technologies being implemented, method requirements, and related challenges are discussed. The differences in analytical procedures for small molecule pharmaceuticals and biopharmaceuticals are pointed out. While a single method or a small set of methods is usually sufficient for quality control in the case of small molecule pharmaceuticals and MS is often not indispensable, a large panel of methods including extensive use of MS must be used for quality control of biopharmaceuticals. Finally, expected development and future trends are outlined.
(© 2023 The Authors. Mass Spectrometry Reviews published by John Wiley & Sons Ltd.)
Databáze: MEDLINE
Externí odkaz: